Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Habib Dable to become President of Bayer's US Pharmaceuticals Business
Habib Dable to become President of Bayer's US Pharmaceuticals Business
While Philip Blake becomes Head of Region Americas for Bayer HealthCare Pharmaceuticals
Novavax makes a management promotion
Novavax makes a management promotion
Jody Lichaa moves up to Vice President, Quality Assurance
Joseph Leveque becomes US Chief Medical Officer of EMD Serono
Joseph Leveque becomes US Chief Medical Officer of EMD Serono
He brings more than 20 years of medical experience to the EMD Serono leadership team
Adents hires James Cummings as Vice President, Americas
Adents hires James Cummings as Vice President, Americas
The serialisation and track and trace specialist recently opened an office in Princeton, NJ
Cocrystal Pharma appoints Douglas Mayers as Chief Medical Officer
Cocrystal Pharma appoints Douglas Mayers as Chief Medical Officer
While interim CEO Jeffrey Meckler takes up the position permanently
Gary Baughman joins M+W Americas as Chief Operating Officer
Gary Baughman joins M+W Americas as Chief Operating Officer
Over the past 30 years he has worked for various technology companies
leon-nanodrugs starts US operations in new York and Chicago
leon-nanodrugs starts US operations in new York and Chicago
Theron (Ted) Odlaug is appointed as Chief Executive Officer
Crown Bioscience expands presence in France
Crown Bioscience expands presence in France
Severine Marrony joins the drug discovery firm as Manager, Business Development in France
Dr Mary Kerr to join NeRRe Therapeutics as CEO
Dr Mary Kerr to join NeRRe Therapeutics as CEO
She will also become an Operating Partner at Advent Life Sciences, one of NeRRe's investors
ObSeva makes two appointments
ObSeva makes two appointments
Elke Bestel joins as Chief Medical Officer and Jean-Pierre Gotteland as Chief Scientific Officer
Abivax makes three new personnel changes
Abivax makes three new personnel changes
Including the appointment of a new Chief Medical Officer
New Director to start at NIBSC in January 2016
New Director to start at NIBSC in January 2016
Dr Christian Schneider will replace Dr Stephen Inglis, who is retiring
High Force Research makes boardroom changes following retirement of Managing Director
High Force Research makes boardroom changes following retirement of Managing Director
Bob Redfern co-founded the firm in 1988
PlaqueTec appoints Dr Tim Brears as CEO
PlaqueTec appoints Dr Tim Brears as CEO
Cambridge firm is pioneering a biomarker-based approach to understanding coronary artery disease
EMD Serono appoints Scott Filosi as Senior Vice President of Managed Markets
EMD Serono appoints Scott Filosi as Senior Vice President of Managed Markets
Filosi brings 20 years of market access experience to the EMD Serono leadership team
David Kaysen named President and CEO of Sun BioPharma
David Kaysen named President and CEO of Sun BioPharma
He brings more than 25 years of healthcare, commercial and public company experience to the firm
Previous
1
…
107
108
109
110
(current)
111
112
113
…
216
Next
Trending Articles
New Managing Director for Shimadzu Europa
Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European organisation and more than 39 years in the company in total
BioDuro appoints Greg Makara to lead discovery chemistry
BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks to strengthen its early-stage drug discovery capabilities.
EyeC expands OEM growth with new business development manager
Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
Three new commercial appointments for Symbiosis
Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across Asia-Pacific, the Middle East and Southern Europe
Lonza nominates Pearl Huang to board
Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug discovery and innovation